simpson 4
Chapter 4: When the Fire Dies - Biotechnology and the Quest for a New Economy
1. Introduction to the Economic Collapse
In late 1985, the Pittsburgh Post-Gazette reported significant unemployment among steelworkers in Pittsburgh:
59% of laid-off steelworkers were still unemployed.
97% of these unemployed workers were male.
Over half of them were older than 40 years.
43% had been unemployed for 13 to 24 months.
Most had only a high school education.
Shift in labor dynamics: More spouses of former steelworkers joined the labor force.
2. Impact on Houston's Economy
Concurrently, the Houston area faced drastic changes due to a collapse in the oil industry:
Oil prices fell from $33/barrel in 1982 to $10/barrel in 1986.
Unemployment rates rose to 9% by January 1983.
The Houston Chronicle noted that 70% of local jobs depended on the oil industry, illustrating a stark economic downturn.
3. Shift to a Medical Metropolis
Despite the economic turmoil, Houston's medical sector began shaping a new economic identity:
High-technology and biomedical experimentation became central to economic development.
Not-for-profit hospitals and universities emerged as economic anchors.
A focus on health care shifted toward a more market-oriented framework centered on “innovation” and “growth.”
4. The Role of Biotechnology in Economic Development
Understanding the rise of biotechnology as economic policy reveals its successes and limitations within the hospital-civic relationship:
Reveals problems of technology transfer and venture capital financing in the region.
Highlights challenges in establishing effective public-private partnerships with limited influence over policy or consumer demand.
Prominent figures recognized the potential of biotechnology for regional economic development, including University of Pittsburgh Chancellor Wesley W. Posvar, who aimed to transform areas like Mon Valley into “Biotech Valley.”
5. Historical Context of Biotechnology's Acceptance
Historical skepticism existed within the academic medical community about commodifying lifesaving medical discoveries:
Jonas Salk's famous reply about the polio vaccine: "There is no patent. Could you patent the sun?"
Prior to the 1980s, the economic value of biomedical research was limited due to:
Difficulty in attracting a skilled workforce.
Issues with patent protection and technology transfer.
Lack of financing for speculative biomedical ventures.
6. Changing Economic Policies and Frameworks
The 1980s brought favorable regulatory changes promoting commercialization of biomedical research:
Deep economic changes in both Pittsburgh and Houston led to a paradigm shift within economic development strategies.
Acknowledgment of the market-oriented approach became prominent, reshaping health care and its relationship to the economy.
7. Labor Market Transformation
Advanced technology created new workforces capable of differing roles:
Workers required higher levels of education and adaptability compared to previous manufacturing roles.
The promotion of educational programs aimed to connect the existing labor force with emerging health careers.
Transition stories:
Joseph Sudar exemplified struggles amid industrial collapse, facing unemployment and lacking resources for reinvention.
Sam Grese found success through education and relocation, working in a booming economy elsewhere after transitioning from steelwork.
Steve Laurer described the pressures of adaptation and survival in the newly transformed labor market.
8. Biotechnology as a Market Strategy
Biotechnology emerged as a focus due to its avoidance of directly tackling hard socio-economic issues like corporate behavior and labor unrest:
Positioned as a hopeful strategy for economic reinvention.
Promoters emphasized the need for research and technology-driven economy rather than addressing dire legacies of industrial decline.
9. Historical Economic Development Efforts
Edward H. Litchfield, a key advocate for regional economic growth through research, described the potential of industrial research, linking it to the prosperity of the region:
Suggested a model similar to successful spaces such as Stanford’s Research Park.
Plans for significant research institutions faced many economic hurdles, ultimately not realized.
10. Biotechnology Growth and Challenges
The 1970s biotechnology revolution, particularly advances in genetics, led to the commercialization potential that the 1980s highlighted:
Recombinant DNA technology broke barriers in biotechnology despite concerns of safety and ethical implications.
The University of Pittsburgh transitioned to become a leader in NIH funding for biomedical research.
Metrics shifted from private funding to public grants as success indicators for institutions involved in biotechnology:
NIH funding became a vital resource for sustaining research initiatives and demonstrating legitimacy.
11. Legislative and Institutional Influences on Biotechnology
The passage of the Bayh-Dole Act in 1980 substantially changed the landscape for university commercialization of research:
Encouraged universities to patent inventions from federally funded research, spurring biotechnology commercialization.
The Supreme Court ruling in Democratic v. Chakrabarty facilitated the patenting of living organisms, enhancing the biotechnology industry’s prospects.
The venture capital market also experienced shifts beneficial to biotechnology firms:
Changes to tax laws induced more investment in venture capital, supporting start-ups.
12. Infrastructural Developments in Pittsburgh
Development efforts by the Foundation for Applied Science and Technology (FAST) promoted technology transfer initiatives:
Aimed to link university research with industry.
Structured to support entrepreneurship in biotechnology and biomedical research.
Local government and business entities took initiative to establish funding frameworks and programs aiding technology and business development:
Creation of the Pittsburgh Seed Fund to provide early-stage investments in biotech.
13. Biotech Development in Houston
Houston's economy, despite an oil-centric past, pivoted to explore advancements in biotechnology:
Development of the Houston Economic Development Council (HEDC) to spearhead economic diversification.
Notable figures like George Mitchell made significant investments in biotechnology and lab facilities in Houston.
14. Biotechnology Partnerships and Collaboration
Multiple institutions played roles in establishing technology transfer structures, promoting cooperation among universities, health systems, and the private sector:
Baylor College of Medicine initiated its internal technology transfer operations.
Partnerships aimed to encourage commercialization of health technologies while addressing concerns regarding relationships with private capital.
15. Shift Towards a Knowledge Economy
The overarching effort in both cities to pivot from junior industries to knowledge-driven economies involved:
Efforts to foster educational capabilities while investing in advanced sectors including biotechnology.
Civic leaders and institutions sought to frame the emerging biotechnological landscape within narratives of economic renewal and hope.
16. Conclusion
Despite efforts, biotechnology did not singularly provide solutions to economic disenfranchisement:
Employment gains in biosciences contrasted against the limited impact on low-skill workers, raising issues of inequality and access to training opportunities.
Both cities worked towards broader economic revitalization strategies directly connecting innovation and community development, emphasizing the continuing challenges faced within these transitions.
Overall Summary
In the late 1980s, Pittsburgh and Houston faced severe economic downturns due to the collapse of the steel and oil industries, respectively. Both cities turned to biotechnology and the medical sector as a strategy for economic reinvention, promoting innovation, growth, and technology transfer. Despite significant investments, legislative changes like the Bayh-Dole Act, and the establishment of new institutions, biotechnology only partially addressed economic disenfranchisement, creating new jobs primarily for high-skilled workers while low-skilled workers often struggled to adapt.
Intro Description
In late 1985, Pittsburgh experienced significant unemployment among its steelworkers, with 59% of laid-off workers still jobless and over half being older than 40. Concurrently, Houston faced drastic economic changes as oil prices plummeted from in 1982 to in 1986, leading to a 9% unemployment rate by January 1983 and 70% of local jobs depending on the ailing oil industry.
Quote
"The Houston Chronicle noted that 70% of local jobs depended on the oil industry, illustrating a stark economic downturn."
Subsection: Biotechnology and the New Economy in Pittsburgh Description
Amidst the collapse of its steel industry, Pittsburgh sought to transform areas like Mon Valley into a "Biotech Valley." University of Pittsburgh Chancellor Wesley W. Posvar recognized the potential of biotechnology for regional economic development. Efforts included promoting educational programs to connect the existing labor force with emerging health careers, though many, like Joseph Sudar, struggled without resources for reinvention. The Foundation for Applied Science and Technology (FAST) was established to link university research with industry and support biotech entrepreneurship, alongside the creation of the Pittsburgh Seed Fund for early-stage investments.
Quote
University of Pittsburgh Chancellor Wesley W. Posvar aimed to transform areas like Mon Valley into “Biotech Valley.”
Subsection: Biotechnology in Houston Description
Houston's economy, reeling from the oil industry collapse, pivoted towards becoming a medical metropolis. High-technology and biomedical experimentation became central to its new economic identity, with not-for-profit hospitals and universities emerging as economic anchors. The Houston Economic Development Council (HEDC) was formed to spearhead diversification efforts, and notable figures like George Mitchell invested significantly in local biotechnology and lab facilities.
Quote
"Oil prices fell from in 1982 to in 1986."
Subsection: Technology Transfer, Venture Capital, and Spin-offs in Houston’s Biotechnology Industry Description
Both cities grappled with challenges in technology transfer and venture capital financing. Historically, the economic value of biomedical research was limited by difficulties in attracting skilled labor, patent protection, and financing for speculative ventures. However, the 1980s brought favorable changes, including the Bayh-Dole Act of 1980, which encouraged universities to patent federally funded research, and a Supreme Court ruling that facilitated the patenting of living organisms. These legislative shifts, coupled with changes to tax laws that induced more investment in venture capital, spurred the growth of biotechnology firms. In Houston, Baylor College of Medicine initiated its own internal technology transfer operations, and investments from figures like George Mitchell supported lab facilities, demonstrating a concrete move towards commercialization and spin-offs.
Quote
"The passage of the Bayh-Dole Act in 1980 substantially changed the landscape for university commercialization of research."
Argument Description
Biotechnology was embraced as a hopeful strategy for economic reinvention in Pittsburgh and Houston, particularly because it allowed civic leaders to focus on a research and technology-driven economy rather than directly confronting deeply rooted socio-economic issues like corporate behavior and labor unrest stemming from industrial decline. It represented a market-oriented approach to health care and its economic relationship.
Quote
"Biotechnology emerged as a focus due to its avoidance of directly tackling hard socio-economic issues like corporate behavior and labor unrest: Positioned as a hopeful strategy for economic reinvention."
Problem Description
Despite significant efforts and investments, biotechnology did not provide a singular or complete solution to economic disenfranchisement in Pittsburgh and Houston. While some employment gains occurred in biosciences, their impact on low-skill workers was limited, exacerbating issues of inequality and access to new training opportunities. Historical skepticism about commodifying medical discoveries (as exemplified by Jonas Salk) also presented an initial hurdle, alongside earlier challenges in attracting a skilled workforce, securing patent protection, and obtaining financing for speculative biomedical ventures.
Quote
Jonas Salk's famous reply about the polio vaccine: "There is no patent. Could you patent the sun?"
Discussion question
Given the successes and limitations observed in Pittsburgh and Houston, to what extent can biotechnology truly serve as a sole solution for economic revitalization and address deep-seated labor market inequalities?
Evidence/Methods Description
The chapter draws on reports from local newspapers (Pittsburgh Post-Gazette, Houston Chronicle) to establish the economic context. It incorporates historical accounts, such as Jonas Salk's stance on medical commodification and Edward H. Litchfield's advocacy for research-driven growth. Legislative changes like the Bayh-Dole Act and Supreme Court rulings are cited as foundational shifts. The narrative is supported by institutional developments (NIH funding, FAST, HEDC) and individual stories (Joseph Sudar, Sam Grese, Steve Laurer) to illustrate the human impact and varying outcomes of the economic transition.
Structure of argument: Description
The argument is structured by first presenting the severe economic crises in Pittsburgh and Houston, establishing the urgent need for new economic strategies. It then details the historical context and the paradigm shift towards biotechnology as a solution, outlining the specific policy changes (e.g., Bayh-Dole Act), institutional developments, and investment efforts in both cities. Finally, it analyzes the outcomes, highlighting both the successes and significant limitations of biotechnology in addressing broader economic disenfranchisement and labor market challenges, concluding that it did not provide a singular solution.